Código QR (código de barras bidimensional)

Asian Subgroup Analysis of Patients in the Phase 2 DeLLphi-301 Study of Tarlatamab for Previously Treated Small Cell Lung Cancer

Abstract Introduction Tarlatamab is a bispecific T-cell engager (BiTE®) immunotherapy that binds delta-like ligand 3 on the surface of small cell lung cancer (SCLC) cells and CD3 on T cells, facilitating T cell-mediated cancer cell lysis. In the primary analysis of the phase 2 DeLLphi-301 study (NCT...

Fuld beskrivelse

Na minha lista:
Principais autores: Myung-Ju Ahn, Byoung Chul Cho, Kadoaki Ohashi, Hiroki Izumi, Jong-Seok Lee, Ji-Youn Han, Chi-Lu Chiang, Shuang Huang, Ali Hamidi, Sujoy Mukherjee, Krista Lin Xu, Hiraoki Akamatsu
Format: Artigo
Sprog:Inglês
Udgivet: Adis, Springer Healthcare 2025-09-01
Serier:Oncology and Therapy
Fag:
Small cell lung cancer (SCLC)
Tarlatamab
DLL3
Bispecific T-cell engager
Asian patients
Online adgang:https://doi.org/10.1007/s40487-025-00372-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker